Dipexium Pharmaceuticals Inc. Daily Stock Analysis

Daily Stock Analysis, DPRX, Dipexium Pharmaceuticals Inc, priceseries

Dipexium Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
1.30
Close
1.34
High
1.35
Low
1.25
Previous Close
1.30
Daily Price Gain
0.04
YTD High
1.75
YTD High Date
Jan 3, 2017
YTD Low
1.05
YTD Low Date
Feb 13, 2017
YTD Price Change
-0.26
YTD Gain
-16.38%
52 Week High
17.75
52 Week High Date
Sep 28, 2016
52 Week Low
1.05
52 Week Low Date
Feb 13, 2017
52 Week Price Change
-10.96
52 Week Gain
-89.12%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 11. 2015
11.98
Mar 4. 2015
13.17
14 Trading Days
9.94%
Link
LONG
May 28. 2015
12.46
Jun 17. 2015
13.99
14 Trading Days
12.28%
Link
LONG
Jul 13. 2015
14.15
Aug 4. 2015
15.92
16 Trading Days
12.48%
Link
LONG
Apr 20. 2016
9.58
May 3. 2016
11.06
9 Trading Days
15.40%
Link
LONG
Aug 1. 2016
10.60
Aug 22. 2016
11.63
15 Trading Days
9.75%
Link
LONG
Sep 9. 2016
13.70
Sep 28. 2016
15.26
13 Trading Days
11.39%
Link
LONG
Dec 23. 2016
2.00
Dec 27. 2016
2.10
1 Trading Days
5.00%
Link
Company Information
Stock Symbol
DPRX
Exchange
NasdaqCM
Company URL
www.dipexiumpharmaceuticals.com
Company Phone
212-269-2834
CEO
David P. Luci
Headquarters
New York
Business Address
14 WALL ST., SUITE 3D, NEW YORK, NY 10005
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001497504
About

Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY.

Description

Dipexium Pharmaceuticals, Inc., a late stage pharmaceutical company, focuses on the development and commercialization of antibiotics in the United States. The company develops Locilex (pexiganan cream 0.8%), a novel topical antibiotic for the treatment of mild infections of diabetic foot ulcers. Dipexium Pharmaceuticals, Inc. was founded in 2010 and is based in New York, New York.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading